Our company has been run by the same family since its foundation. We have made a conscious decision – in the interest of our clients first and foremost – not to be part of any large groups or investment funds.
Every new contract is a challenge to our plant, our culture and ourapproach. Routine has never been part of our ethos, it has always been our aim to provide a novel and unique service, tailor-made to every client. We know how to listen and understand.
We are fully aware of the value of confidentiality, especially when our customers develop new molecules or dosage forms, and precisely thanks to our independence it is something we can guarantee with absolute confidence.
In the industry we are recognized as the technological forefront, holding a 3 to 5 year advantage inmicronization processes: we are synonymous with micronization, we have always designed our own machinery and technical solutions, exclusively for our clients.
Munit will participate the the this years Formulation and Drug Delivery Summit in San Diego (USA) DCAT New York (USA) and CPhI Tokyo (Japan). We are looking forward seeing you at one of this events!
MUNIT will participate at this year’s European DDF-Summit in Berlin, from March 11th to March 13th 2018. You are welcome to visit us at our booth!
MUnit is exhibiting at the forthcoming Drug Delivery to the Lungs (DDL) conference at Edinburgh International Conference Centre. The event is Europe’s premier conference and industry exhibition dedicated to pulmonary and nasal drug delivery. It runs from 12-14 December 2018 MUnit, your partner for the micronisation of API’s and High Potent Materials, will be pleased …
MUNIT has announced it will be participating at the 5th Annual Controlled & Modified Drug Release Summit in Philadelphia, US. The event will take place from 28-29 November at the Marriot Philadelphia Downtown Hotel. This industry-leading event will bring together key decision makers and innovators within the controlled and modified drug release market, where particle …
MUNIT announces its participation at the 6th Annual World HPAPI congress in Basel, Switzerland. The event will take place from October 29th to October 31st and is co-located with the European Antibody , World Biosimilar and World Immunotherapy Congress. Pls. visit us at booth 33.
MUnit, JETPHARMA and Microchem have announced they will be attending this year’s CPhI Woldwide and the co-located events ICSE, InnoPack, P-MEC and FDF. Taking place from the 9 October to 10 October at IFEMA Feria de Madrid, the events are expected to host more than 45,000 pharmaceutical professionals. MUnit and its affiliates JETPHARMA and Microchem …
MUNIT’s commercial Director Dr. Maurizio Schiavazzi would like to welcome you at the largest USA-based API and Pharmaceutical Ingredients show attracting annually 700-800 customers, project and executive management and business development personnel from the pharmaceutical, biotech, chemical, and chemistry services industries from 30 countries.
MUNIT will participate at this year’s American DDF-Summit in San Francisco, from September 10th to September 11th 2018. Pls. visit us at our booth!
Munit SA has announced it will be participate as an exhibitor at the 4th Annual Formulation & Drug Delivery Congress, 8 – 9 May 2018 in London. Over 350 senior level experts will be attending the 2018 event to network about the latest developments & participate in presentations covering the below main areas: • Large …
MUNIT is glad to announce its participation to both events and its Sales Staff will be delighted to meet you.
The 2018th edition of the RDD Conference (Respiratory Drug Delivery) will be held at the JW Marriott in Tucson, Arizona, from April 22-26, 2018. About 600 participants are expected at this international symposium dedicated to themes surrounding nasal and pulmonary drug delivery. The RDD conference includes Seminars, cutting-edge presentations on new technologies and services related …
We are looking forward to welcoming you at the 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology from19 March to 22 March 2018 in Granada, Spain We are happy to welcome you at our booth no. 27
MUnit is glad to announce its participation in the forthcoming DCAT. The exhibition will take place in New York from 19 to 22 March 2018. We will be very pleased to tell you more about our activities based on 40 years of experience in the micronisation of APIs and high-potent active pharmaceutical ingredients (HPAPI). Please …
We invite you to join us at stand 34 during the World HPAPI Congress , co-located with the European Antibody Congress, World Biosimilar Congress and the World Immunotherapy Congress from October 31st to November 2nd in Basel, Switzerland.
Munit and its affiliates Jetpharma and Microchem welcome you at the CPhI in Frankfurt. Our technical and commercial staff will be pleased to present you our view on the world of micronization. Join us in hall 8 J62.
JETPHARMA, micronization partner of MUNIT, has just completed the renewal and enlargement of its QC Lab. New lab areas have been created and new instruments of analysis installed , this will increase the in house capacity for both internal and external analytical request. This renovation is part of 2017 plan of investments, decided by Martinoli’s …
Our Commercial Director Mr. Schiavazzi will be pleased to meet you at this year’s PharmaChemOutsourcing in Long Beach, the largest US-based API show. We would like to introduce MUNIT, the new consultancy company, born from the synergy of JETPHARMA (Switzerland) and MICROCHEM (Italy) and based on the 40 years of their experience in the micronization …
We will be pleased to meet you at the AFI Symposium in Rimini. Mr. Heidenreich will be at your disposal to answer to all your questions and needs. We will be pleased to meet you at the AFI Symposium in Rimini.
First, the accurate respect of the contents and time-plan; second, it aims at constantly observing the specific needs, in a welcoming and dedicated atmosphere.
MUnit daily operates for the pharmaceutical sector, which is one of the most process-improvement oriented markets, for example with the creation of guidelines that allows managing the complexity of the various production processes. These guidelines are also the core of some dedicated abilities in order to profile the production quality’s value also in the form of activities that have to be part of the planning of the process itself.
Therefore, MUnit can support with its own know-how, within the sphere of the micronization service, those customers using the DoE/QbD approach for their processes.
We are willing to listen to requests and gather nuances and, above all, we have a very huge vision of the possible answers and solutions.
Finally, we are trained to the solution finding of requests and problems: MUnit was specifically created with this purpose, gaining from the strong support of two great companies.
Mr. Maurizio Schiavazzi
Mr. Giovanni Frigerio
Ms. Katia Zocca
Mr. Uwe Heidenreich
Business Development Manager
Mr. Massimo Dal Bosco
Business Development Manager
Via Crocicchio Cortogna 6
T. +41 (0)91 910 30 80